Taking Stock
Shire's Ornskov on $1 Billion Potential for Dry-Eye Drug(Audio)
- Author: Vários
- Narrator: Vários
- Publisher: Podcast
- Duration: 0:08:45
- More information
Informações:
Synopsis
(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox. GUEST: Shire CEO Flemming Ornskov on the outlook for the company after getting FDA approval for Xiidra drops to treat dry-eye disease.
